{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:16:57Z","timestamp":1793971017947,"version":"4.8.0"},"reference-count":56,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nasopharyngeal carcinoma (NPC), an EBV-associated malignancy, is highly metastatic compared with other head and neck tumors, perhaps because of its viral link. Here, we show that the principal EBV oncoprotein, latent membrane protein 1 (LMP1), induces epithelial-mesenchymal transition (EMT) via Twist, a master transcriptional regulator in embryogenesis and newly implicated in metastasis, which, in turn, are likely to contribute to the highly metastatic character of NPC. LMP1 could induce EMT and its associated cell motility and invasiveness in a cell culture model, whereas expression of Twist small interfering RNA reversed LMP1-induced EMT. In diverse EBV-infected cell lines, expression of Twist correlates with expression of LMP1. Dominant-negative LMP1 could suppress Twist expression in EBV-positive cells, whereas LMP1 could induce Twist in EBV-negative nasopharyngeal cells. LMP1 signals through the nuclear factor-\u03baB pathway, and an I\u03baB superrepressor inhibited induction of Twist by LMP1. Finally, in human NPC tissues, expression of Twist and LMP1 is directly correlated and expression of Twist is associated with metastasis clinically. These results suggest that induction of Twist by a human viral oncoprotein LMP1 directly contributes to the metastatic nature of NPC. [Cancer Res 2007;67(5):1970\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-3933","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T08:03:59Z","timestamp":1172822639000},"page":"1970-1978","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":184,"title":["Twist and Epithelial-Mesenchymal Transition Are Induced by the EBV Oncoprotein Latent Membrane Protein 1 and Are Associated with Metastatic Nasopharyngeal Carcinoma"],"prefix":"10.1158","volume":"67","author":[{"given":"Toshiyuki","family":"Horikawa","sequence":"first","affiliation":[{"name":"1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina;"},{"name":"2Department of Otolaryngology, School of Medicine, Kanazawa University, Kanazawa, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"3Whitehead Institute for Biomedical Research, Cambridge, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kondo","sequence":"additional","affiliation":[{"name":"2Department of Otolaryngology, School of Medicine, Kanazawa University, Kanazawa, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Yoshizaki","sequence":"additional","affiliation":[{"name":"2Department of Otolaryngology, School of Medicine, Kanazawa University, Kanazawa, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Joab","sequence":"additional","affiliation":[{"name":"4Pharmacologie Experimentale et Clinique, Institut Federatif de Recherche Saint Louis, Institut de Ge\u0308ne\u0308tique Moleculaire, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Furukawa","sequence":"additional","affiliation":[{"name":"2Department of Otolaryngology, School of Medicine, Kanazawa University, Kanazawa, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Pagano","sequence":"additional","affiliation":[{"name":"1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,3,1]]},"reference":[{"key":"2022061623352108200_B1","doi-asserted-by":"crossref","unstructured":"Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell\u20082004; 5: 423\u20138.","DOI":"10.1016\/S1535-6108(04)00119-9"},{"key":"2022061623352108200_B2","doi-asserted-by":"crossref","unstructured":"Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol\u20082004; 14: 453\u201371.","DOI":"10.1016\/j.semcancer.2004.06.009"},{"key":"2022061623352108200_B3","doi-asserted-by":"crossref","unstructured":"Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol\u20082002; 12: 431\u201341.","DOI":"10.1016\/S1044579X0200086X"},{"key":"2022061623352108200_B4","doi-asserted-by":"crossref","unstructured":"Kaye KM, Izumi MK, Mosialos G, Kieff E. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation: fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol\u20081995; 69: 675\u201383.","DOI":"10.1128\/jvi.69.2.675-683.1995"},{"key":"2022061623352108200_B5","doi-asserted-by":"crossref","unstructured":"Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell\u20081985; 43: 831\u201340.","DOI":"10.1016\/0092-8674(85)90256-9"},{"key":"2022061623352108200_B6","doi-asserted-by":"crossref","unstructured":"Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V, Raab-Traub N. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A\u20081998; 95: 11963\u20138.","DOI":"10.1073\/pnas.95.20.11963"},{"key":"2022061623352108200_B7","doi-asserted-by":"crossref","unstructured":"Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell\u20081995; 80: 389\u201399.","DOI":"10.1016\/0092-8674(95)90489-1"},{"key":"2022061623352108200_B8","doi-asserted-by":"crossref","unstructured":"Hatzivassiliou E, Miller WE, Raab-Traub N, Kieff E, Mosialos GJ. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-\u03ba B, and stress-activated protein kinase. Immunol\u20081998; 160: 1116\u201321.","DOI":"10.4049\/jimmunol.160.3.1116"},{"key":"2022061623352108200_B9","unstructured":"Liebowitz D, Kieff E. Epstein-Barr virus. In The human herpesviruses. In: Roizman B, Whitley RJ, Lopez C, editors. New York: Raven Press; 1993. p. 107\u201372."},{"key":"2022061623352108200_B10","doi-asserted-by":"crossref","unstructured":"Pathmanathan RU, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med\u20081995; 333: 693\u20138.","DOI":"10.1056\/NEJM199509143331103"},{"key":"2022061623352108200_B11","doi-asserted-by":"crossref","unstructured":"Lo AK, Liu Y, Wang XH, et al. Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1. Lab Invest\u20082003; 83: 697\u2013709.","DOI":"10.1097\/01.LAB.0000067480.44925.10"},{"key":"2022061623352108200_B12","unstructured":"Wakisaka N, Pagano JS. Epstein-Barr virus induces invasion and metastasis factors. Anticancer Res\u20082003; 23: 2133\u20138."},{"key":"2022061623352108200_B13","unstructured":"Yoshizaki T, Wakisaka N, Pagano JS. Chapter 12: Epstein-Barr virus, invasion and metastasis. In: Robertson ES, editor. Epstein-Barr virus. Norfolk (United Kingdom): Caister Academic Press; 2005. p. 171\u201396."},{"key":"2022061623352108200_B14","unstructured":"Raab-Traub N, Flynn K, Klein C, et al. EBV associated malignancies. J Exp Pathol\u20081987; 3: 449\u201356."},{"key":"2022061623352108200_B15","doi-asserted-by":"crossref","unstructured":"Hu LF, Chen F, Zhen QF, et al. Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. Eur J Cancer\u20081995; 31: 658\u201360.","DOI":"10.1016\/0959-8049(94)00468-K"},{"key":"2022061623352108200_B16","doi-asserted-by":"crossref","unstructured":"Horikawa T, Yoshizaki T, Sheen TS, Lee SY, Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer\u20082000; 89: 715\u201323.","DOI":"10.1002\/1097-0142(20000815)89:4<715::AID-CNCR1>3.0.CO;2-9"},{"key":"2022061623352108200_B17","doi-asserted-by":"crossref","unstructured":"Horikawa T, Sheen TS, Takeshita H, Sato H, Furukawa M, Yoshizaki T. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am J Pathol\u20082001; 159: 27\u201333.","DOI":"10.1016\/S0002-9440(10)61669-0"},{"key":"2022061623352108200_B18","doi-asserted-by":"crossref","unstructured":"Sarac S, Akyol MU, Kanbur B, et al. Bcl-2 and LMP1 expression in nasopharyngeal carcinomas. Am J Otolaryngol\u20082001; 22: 377\u201382.","DOI":"10.1053\/ajot.2001.28071"},{"key":"2022061623352108200_B19","doi-asserted-by":"crossref","unstructured":"Kondo S, Wakisaka N, Schell MJ, et al. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int J Cancer\u20082005; 115: 368\u201376.","DOI":"10.1002\/ijc.20849"},{"key":"2022061623352108200_B20","doi-asserted-by":"crossref","unstructured":"Kondo S, Seo SY, Yoshizaki T, et al. EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1{\u03b1} through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res\u20082006; 66: 9870\u20137.","DOI":"10.1158\/0008-5472.CAN-06-1679"},{"key":"2022061623352108200_B21","unstructured":"Murono S, Yoshizaki T, Sato H, Takesita H, Furukawa M, Pagano JS. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res\u20082000; 60: 2555\u201361."},{"key":"2022061623352108200_B22","doi-asserted-by":"crossref","unstructured":"Murono S, Inoue H, Tanabe T, et al. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A\u20082001; 98: 6905\u201310.","DOI":"10.1073\/pnas.121016998"},{"key":"2022061623352108200_B23","doi-asserted-by":"crossref","unstructured":"Takeshita H, Yoshizaki T, Miller WE, Raab-Traub N, Pagano JS. The Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J Virol\u20081999; 173: 5548\u201355.","DOI":"10.1128\/JVI.73.7.5548-5555.1999"},{"key":"2022061623352108200_B24","unstructured":"Wakisaka N, Murono S, Yoshizaki T, Furukawa M, Pagano JS. Epstein-Barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. Cancer Res\u20082002; 62: 6337\u201344."},{"key":"2022061623352108200_B25","doi-asserted-by":"crossref","unstructured":"Wakisaka N, Kondo S, Yoshizaki T, Murono S, Pagano JS. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1\u03b1. Mol Cell Biol\u20082004; 24: 5223\u201334.","DOI":"10.1128\/MCB.24.12.5223-5234.2004"},{"key":"2022061623352108200_B26","doi-asserted-by":"crossref","unstructured":"Yoshizaki T, Sato H, Furukawa M, Pagano JS. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci U S A\u20081998; 95: 3261\u20136.","DOI":"10.1073\/pnas.95.7.3621"},{"key":"2022061623352108200_B27","unstructured":"Yoshizaki T, Horikawa T, Qing-Chun R, et al. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin Cancer Res\u20082001; 7: 1946\u201351."},{"key":"2022061623352108200_B28","doi-asserted-by":"crossref","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer\u20082002; 2: 442\u201354.","DOI":"10.1038\/nrc822"},{"key":"2022061623352108200_B29","doi-asserted-by":"crossref","unstructured":"Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol\u20082005; 17: 548\u201358.","DOI":"10.1016\/j.ceb.2005.08.001"},{"key":"2022061623352108200_B30","doi-asserted-by":"crossref","unstructured":"Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell\u20082004; 118: 277\u20139.","DOI":"10.1016\/j.cell.2004.07.011"},{"key":"2022061623352108200_B31","doi-asserted-by":"crossref","unstructured":"Nicholls JM, Agathangelou A, Fung K, Zeng X, Niedobitek G. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma. J Pathol\u20081997; 183: 164\u20138.","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<164::AID-PATH919>3.0.CO;2-J"},{"key":"2022061623352108200_B32","unstructured":"Shanmugaratnam K, Sobin LH. In: Shanmugaratnam K, Sobin LH, editors. International histological classification of tumours: no 19. Geneva: WHO; 1991. p. 32\u20133."},{"key":"2022061623352108200_B33","doi-asserted-by":"crossref","unstructured":"Marks JE, Phillips JL, Menck HR. The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer\u20081998; 83: 582\u20138.","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<582::AID-CNCR29>3.0.CO;2-R"},{"key":"2022061623352108200_B34","doi-asserted-by":"crossref","unstructured":"Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell\u20082004; 117: 927\u201339.","DOI":"10.1016\/j.cell.2004.06.006"},{"key":"2022061623352108200_B35","doi-asserted-by":"crossref","unstructured":"Maestro R, Dei Tos AP, Hamamori Y, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev\u20081999; 13: 2207\u201317.","DOI":"10.1101\/gad.13.17.2207"},{"key":"2022061623352108200_B36","doi-asserted-by":"crossref","unstructured":"van Doorn R, Dijkman R, Vermeer MH, et al. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res\u20082004; 64: 5578\u201386.","DOI":"10.1158\/0008-5472.CAN-04-1253"},{"key":"2022061623352108200_B37","doi-asserted-by":"crossref","unstructured":"Kwok WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res\u20082005; 65: 5153\u201362.","DOI":"10.1158\/0008-5472.CAN-04-3785"},{"key":"2022061623352108200_B38","doi-asserted-by":"crossref","unstructured":"Elias MC, Tozer KR, Silber JR, et al. TWIST is expressed in human gliomas and promotes invasion. Neoplasia\u20082005; 7: 824\u201337.","DOI":"10.1593\/neo.04352"},{"key":"2022061623352108200_B39","doi-asserted-by":"crossref","unstructured":"Lee TK, Poon RT, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res\u20082006; 12: 5369\u201376.","DOI":"10.1158\/1078-0432.CCR-05-2722"},{"key":"2022061623352108200_B40","doi-asserted-by":"crossref","unstructured":"Contreras-Brodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. J Gen Virol\u20081991; 72: 3025\u201333.","DOI":"10.1099\/0022-1317-72-12-3025"},{"key":"2022061623352108200_B41","doi-asserted-by":"crossref","unstructured":"Arbach H, Viglasky V, Lefeu F, et al. Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J Virol\u20082006; 80: 845\u201353.","DOI":"10.1128\/JVI.80.2.845-853.2006"},{"key":"2022061623352108200_B42","doi-asserted-by":"crossref","unstructured":"Takimoto T, Sato H, Ogura H, Tanaka S, Umeda R. The difference in tumorigenicity between Epstein-Barr virus (EBV) genome-positive and genome-negative epithelial hybrid cell lines derived from the human nasopharynx. Laryngoscope\u20081988; 98: 1334\u20138.","DOI":"10.1288\/00005537-198812000-00010"},{"key":"2022061623352108200_B43","doi-asserted-by":"crossref","unstructured":"Zhang L, Wu L, Hong K, Pagano JS. Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7. J Virol\u20082001; 75: 12393\u2013401.","DOI":"10.1128\/JVI.75.24.12393-12401.2001"},{"key":"2022061623352108200_B44","doi-asserted-by":"crossref","unstructured":"Stewart SA, Dykxhoorn DM, Palliser D, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA\u20082003; 9: 493\u2013501.","DOI":"10.1261\/rna.2192803"},{"key":"2022061623352108200_B45","unstructured":"Howe LR, Watanabe O, Leonard J, Brown AM. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res\u20082003; 63: 1906\u201313."},{"key":"2022061623352108200_B46","doi-asserted-by":"crossref","unstructured":"Gershburg E, Marschall M, Hong K, Pagano JS. Expression and localization of the Epstein-Barr virus-encoded protein kinase. J Virol\u20082004; 78: 12140\u20136.","DOI":"10.1128\/JVI.78.22.12140-12146.2004"},{"key":"2022061623352108200_B47","doi-asserted-by":"crossref","unstructured":"Horikawa T, Kaizaki Y, Kato H, Furukawa M, Yoshizaki T. Expression of interleukin-8 receptor A predicts poor outcome in patients with nasopharyngeal carcinoma. Laryngoscope\u20082005; 115: 62\u20137.","DOI":"10.1097\/01.mlg.0000150675.37860.f7"},{"key":"2022061623352108200_B48","doi-asserted-by":"crossref","unstructured":"Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol\u20082005; 12: 488\u201396.","DOI":"10.1245\/ASO.2005.04.010"},{"key":"2022061623352108200_B49","unstructured":"Huen DS, Henderson SA, Carter DC, Rowe M. The Epstein-Barr virus latent membrane protein 1 (LMP1) mediates activation of NF-\u03baB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene\u20081995; 10: 549\u201360."},{"key":"2022061623352108200_B50","doi-asserted-by":"crossref","unstructured":"Thompson EW, Newgreen DF. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res\u20082005; 65: 5991\u20135.","DOI":"10.1158\/0008-5472.CAN-05-0616"},{"key":"2022061623352108200_B51","doi-asserted-by":"crossref","unstructured":"Gires O, Zimber-Strobl U, Gonnella R, et al. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J\u20081997; 16: 6131\u201340.","DOI":"10.1093\/emboj\/16.20.6131"},{"key":"2022061623352108200_B52","doi-asserted-by":"crossref","unstructured":"Izumi KM, Kieff ED. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-\u03baB. Proc Natl Acad Sci U S A\u20081997; 94: 12592\u20137.","DOI":"10.1073\/pnas.94.23.12592"},{"key":"2022061623352108200_B53","doi-asserted-by":"crossref","unstructured":"Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J\u20081997; 16: 6478\u201385.","DOI":"10.1093\/emboj\/16.21.6478"},{"key":"2022061623352108200_B54","doi-asserted-by":"crossref","unstructured":"Thornburg NJ, Kulwichit W, Edwards RH, Shair KH, Bendt KM, Raab-Traub N. LMP1 signaling and activation of NF-\u03baB in LMP1 transgenic mice. Oncogene\u20082006; 25: 288\u201397.","DOI":"10.1038\/sj.onc.1209023"},{"key":"2022061623352108200_B55","doi-asserted-by":"crossref","unstructured":"Furlong EE, Andersen EC, Null B, White KP, Scott MP. Patterns of gene expression during Drosophila mesoderm development. Science\u20082001; 293: 1629\u201333.","DOI":"10.1126\/science.1062660"},{"key":"2022061623352108200_B56","doi-asserted-by":"crossref","unstructured":"Meulemans D, Bronner-Fraser M. Gene-regulatory interactions in neural crest evolution and development. Dev Cell\u20082004; 7: 291\u20139.","DOI":"10.1016\/j.devcel.2004.08.007"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/5\/1970\/2866940\/1970.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/5\/1970\/2866940\/1970.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T20:47:04Z","timestamp":1683751624000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/5\/1970\/534449\/Twist-and-Epithelial-Mesenchymal-Transition-Are"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,3,1]]},"published-print":{"date-parts":[[2007,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-3933","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,1]]}}}